Cotreatment with the kappa opioid agonist U69593 enhances locomotor sensitization to the D2/D3 dopamine agonist quinpirole and alters dopamine D2 receptor and prodynorphin mRNA expression in rats

By Perreault Melissa   Graham Dawn   Scattolon Sarah   Wang Yufang   Szechtman Henry   Foster Jane  

Psychopharmacology, Vol. 194, Iss. 4, 2007-11 ,pp. : 485-496

Springer Publishing Company

Access to resources Recommend Favorite

Effects of a partial dopamine D 2 -like agonist on the cocaine-induced behavioral sensitization of preweanling rats

By Sibole J.M.   Matea P.J.   Krall C.M.   McDougall S.A.  

Pharmacology Biochemistry and Behavior, Vol. 76, Iss. 1, 2003-08 ,pp. : 27-34

Elsevier

Access to resources Recommend Favorite

-Opioid receptor agonist-induced prolactin release in primates is blocked by dopamine D 2 -like receptor agonists

By Butelman E.R.   Kreek M.-J.  

European Journal of Pharmacology, Vol. 423, Iss. 2, 2001-07 ,pp. : 243-249

Elsevier

Access to resources Recommend Favorite

Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D 2 post-synaptic receptor agonist

By Smith H.P.   Nichols D.E.   Mailman R.B.   Lawler C.P.  

European Journal of Pharmacology, Vol. 323, Iss. 1, 1997-03 ,pp. : 27-36

Elsevier

Access to resources Recommend Favorite

Dopamine D 2 receptor antagonists prevent 9 -tetrahydrocannabinol-induced antinociception in rats

By Carta G.   Gessa G.L.   Nava F.  

European Journal of Pharmacology, Vol. 384, Iss. 2, 1999-11 ,pp. : 153-156

Elsevier

Access to resources Recommend Favorite